English  |  正體中文  |  简体中文  |  总笔数 :2817094  
造访人次 :  27665005    在线人数 :  1278
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

跳至: [ 中文 ] [ 数字0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
请输入前几个字:   

显示项目 277576-277600 / 2307984 (共92320页)
<< < 11099 11100 11101 11102 11103 11104 11105 11106 11107 11108 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2020-06-16T07:53:23Z Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA Tien F.-M.;Hou H.-A.;Tang J.-L.;Kuo Y.-Y.;Chen C.-Y.;Tsai C.-H.;Yao M.;Lin C.-T.;Li C.-C.;Huang S.-Y.;Ko B.-S.;Hsu S.-C.;Wu S.-J.;Liu J.-H.;Chou S.-C.;Tsay W.;Tseng M.-H.;Liu M.-C.;Liu C.-W.;Liang-In Lin;Chou W.-C.;Tien H.-F.; Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; LIANG-IN LIN; Chou W.-C.; Tien H.-F.
臺大學術典藏 2021-07-21T07:23:26Z Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA TIEN FENG-MING; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F.
臺大學術典藏 2018 Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA Tang J.-L.; Hou H.-A.; Tien F.-M.; Tien H.-F.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; MING YAO; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.
臺大學術典藏 2021-01-12T12:53:48Z Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; SHANG-YI HUANG; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F.
臺大學術典藏 2021-07-22T03:35:55Z Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; LIU JIA-HAU; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F.
臺大學術典藏 2021-01-05T02:30:55Z Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA Lin C.-T.; Li C.-C.; Yao M.; Chen C.-Y.; Tsai C.-H.; Kuo Y.-Y.; Tang J.-L.; Hou H.-A.; Tien F.-M.; Tien H.-F.; Chou W.-C.; Lin L.-I.; Liu C.-W.; Liu M.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; SHENG-CHIEH CHOU; Tsay W.; Tseng M.-H.
臺大學術典藏 2021-01-06T03:58:22Z Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA Tien F.-M.; Hou H.-A.; JIH-LUH TANG; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F.
國立成功大學 2016-11-12 Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial Liou, Jyh-Ming;Fang, Yu-Jen;Chen, Chieh-Chang;Bair, Ming-Jong;Chang, Chi-Yang;Lee, Yi-Chia;Chen, Mei-Jyh;Chen, Chien-Chuan;Tseng, Cheng-Hao;Hsu, Yao-Chun;Lee, Ji-Yuh;Yang, Tsung-Hua;Luo, Jiing-Chyuan;Chang, Chun-Chao;Chen, Chi-Yi;Chen, Po-Yueh;Shun, Chia-Tung;Hsu, Wen-Feng;Hu, Wen-Hao;Chen, Yen-Nien;Sheu, Bor-Shyang;Lin, Jaw-Town;Wu, Jeng-Yih;El-Omar, Emad M.;Wu, Ming-Shiang
國立臺灣大學 2016 Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial Liou, Jyh-Ming; Fang, Yu-Jen; Chen, Chieh-Chang; Bair, Ming-Jong; Chang, Chi-Yang; Lee, Yi-Chia; Chen, Mei-Jyh; Chen, Chien-Chuan; Tseng, Cheng-Hao; Hsu, Yao-Chun; Lee, Ji-Yuh; Yang, Tsung-Hua; Luo, Jiing-Chyuan; Chang, Chun-Chao; Chen, Chi-Yi; Chen, Po-Yueh; Shun, Chia-Tung; Hsu, Wen-Feng; Hu, Wen-Hao; Chen, Yen-Nien; Sheu, Bor-Shyang; Lin, Jaw-Town; Wu, Jeng-Yih; El-Omar, Emad M.; Wu, Ming-Shiang; 許文峰; 胡文皓; 林肇堂; 陳美志; 吳明修; 李宜家; 李基裕; 劉志銘; 孫家棟; 吳明賢; 陳建全; 方佑仁; 陳介章
臺大學術典藏 2018-09-10T15:37:40Z Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial Liou, Jyh-Ming;Fang, Yu-Jen;Chen, Chieh-Chang;Bair, Ming-Jong;Chang, Chi-Yang;Lee, Yi-Chia;Chen, Mei-Jyh;Chen, Chien-Chuan;Tseng, Cheng-Hao;Hsu, Yao-Chun;Lee, Ji-Yuh;Yang, Tsung-Hua;Luo, Jiing-Chyuan;Chang, Chun-Chao;Chen, Chi-Yi;Chen, Po-Yueh;Shun, Chia-Tung;Hsu, Wen-Feng;Hu, Wen-Hao;Chen, Yen-Nien;Sheu, Bor-Shyang;Lin, Jaw-Town;Wu, Jeng-Yih;El-Omar, Emad M.;Wu, Ming-Shiang; Liou, J.-M. and Fang, Y.-J. and Chen, C.-C. and Bair, M.-J. and Chang, C.-Y. and Lee, Y.-C. and Chen, M.-J. and Chen, C.-C. and Tseng, C.-H. and Hsu, Y.-C. and Lee, J.-Y. and Yang, T.-H. and Luo, J.-C. and Chang, C.-C. and Chen, C.-Y. and Chen, P.-Y. and Shun, C.-T. and Hsu, W.-F. and Hu, W.-H. and Chen, Y.-N. and Sheu, B.-S. and Lin, J.-T. and Wu, J.-Y. and El-Omar, E.M. and Wu, M.-S.; 許文峰;胡文皓;林肇堂;陳美志;吳明修;李宜家;李基裕;劉志銘;孫家棟;吳明賢;陳建全;方佑仁;陳介章; WEN-FENG HSU; Liou, Jyh-Ming; WEN-HAO HU; Fang, Yu-Jen; Chen, Chieh-Chang; JYH-MING LIOU; Bair, Ming-Jong; YI-CHIA LEE; MING-SHIANG WU; Chang, Chi-Yang; Lee, Yi-Chia; Chen, Mei-Jyh; Chen, Chien-Chuan; Tseng, Cheng-Hao; Hsu, Yao-Chun; Lee, Ji-Yuh; Yang, Tsung-Hua; Luo, Jiing-Chyuan; Chang, Chun-Chao; Chen, Chi-Yi; Chen, Po-Yueh; Shun, Chia-Tung; Hsu, Wen-Feng; Hu, Wen-Hao; Chen, Yen-Nien; Sheu, Bor-Shyang; Lin, Jaw-Town; Wu, Jeng-Yih; El-Omar, Emad M.; Wu, Ming-Shiang
臺大學術典藏 2020-11-02T02:04:25Z Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; MING-SHIANG WU; Taiwan Gastrointestinal Disease; Helicobacter Consortium; Chang C.-C.; Luo J.-C.; Yang T.-H.; Lee J.-Y.; Hsu Y.-C.; Chen C.-C.; Tseng C.-H.; Chen M.-J.; Lee Y.-C.; Chang C.-Y.; Bair M.-J.; Chen C.-C.; Fang Y.-J.; Liou J.-M.
臺大學術典藏 2020-11-27T03:28:37Z Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial Liou J.-M.; Fang Y.-J.; CHIEH-CHANG CHEN; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chien-Chuan Chen; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2021-02-02T05:45:15Z Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial Liou J.-M.;Fang Y.-J.;Chen C.-C.;Bair M.-J.;Chang C.-Y.;Yi-Chia Lee;Chen M.-J.;Chen C.-C.;Tseng C.-H.;Hsu Y.-C.;Lee J.-Y.;Yang T.-H.;Luo J.-C.;Chang C.-C.;Chen C.-Y.;Chen P.-Y.;Shun C.-T.;Hsu W.-F.;Hu W.-H.;Chen Y.-N.;Sheu B.-S.;Lin J.-T.;Wu J.-Y.;El-Omar E.M.;Wu M.-S.;Taiwan Gastrointestinal Disease;Helicobacter Consortium; Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; YI-CHIA LEE; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2021-03-18T02:02:34Z Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; CHIA-TUNG SHUN; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease and Helicobacter Consortium
臺大學術典藏 2021-05-27T08:20:49Z Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial JYH-MING LIOU; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2021-10-18T06:30:00Z Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; YEN-NIEN CHEN; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2022-02-18T06:28:58Z Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; WEN-FENG HSU; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2022-02-14T06:28:49Z Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial Liou J.-M.; YU-JEN FANG; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2022-02-18T08:26:04Z Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial Liou J.-M.; Fang Y.-J.; CHIEH-CHANG CHEN; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; CHIEH-CHANG CHEN; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2022-02-18T08:46:50Z Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial Liou J.-M.; Fang Y.-J.; CHIEN-CHUAN CHEN; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; CHIEN-CHUAN CHEN; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2021-02-02T02:21:08Z Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; MING-SHIANG WU; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2021-02-18T08:38:05Z Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial Liou J.-M.; Fang Y.-J.; Chieh-Chang Chen; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; CHIEN-CHUAN CHEN; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2022-09-07T06:49:53Z Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; YI-CHIA LEE; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium
義守大學 2012-01 Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract Wen-Lun Wang;Wei-Lun Chang;Yi-Chun Yeh;Ching-Tai Lee;Chi-Yang Chang;Jaw-Town Lin;Bor-Shyang Sheu
國立成功大學 2013-06 Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract Wang, Wen-Lun; Chang, Wei-Lun; Yeh, Yi-Chun; Lee, Ching-Tai; Chang, Chi-Yang; Lin, Jaw-Town; Sheu, Bor-Shyang

显示项目 277576-277600 / 2307984 (共92320页)
<< < 11099 11100 11101 11102 11103 11104 11105 11106 11107 11108 > >>
每页显示[10|25|50]项目